Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
NCT Number: NCT00894348
To determine factors associated with a positive yield of malignancy on biliary brush cytology obtained by ERCP.
Looking for future studies?
Notify MeAll sexes
Observational
Cleveland, Ohio, 44195, United States
There are only 3 studies available that have tried to evaluate factors influencing the yield of brush cytology. Two of the 3 studied one parameter. The third study, which is also the largest, reported on 199 samples which the authors evaluated in a retrospect fashion. We plan to conduct a larger study assessing several other factors that have not been studied before. The study findings would help develop strategies to improve sensitivity of brush cytology specimens. This would ultimately result in more effective use of health care resources and improve patient outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years
The Cleveland Clinic
Other
EXEMPT: Prospective Factors Predicting Positive Yields on Biliary Brush Cytology During Endoscopic Retrograde Cholangio-pancreatography (ERCP)
Acronym: ERCP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04572711
Adenocarcinoma, Biliary Stricture
Rochester, Minnesota, United States
View Trial DetailsNCT05826639
Bile Duct Diseases, Biliary Stricture
Rochester, Minnesota, United States
View Trial DetailsNCT05761496
Biliary Stricture, Stent Stenosis
Roma, Italy
View Trial DetailsNCT06258824
Adenocarcinoma, Ampullary Cancer
London, United Kingdom
View Trial Details